The apparent contradiction of Cav3.2 mRNA levels being negatively associated with survival in ER+ cancers and positively associated with survival with chemotherapy in HER-positive breast cancers, may be reflective not only of potential differential contribution of calcium signalling in different breast cancer subtypes but also in the diversity of the Ca2+-signal. This evidence concerns the gene ESR1 and cancer.